Wood, J.; Abdelrazig, S.; Evseev, S.; Ortori, C.; Castellanos-Uribe, M.; May, S.T.; Barrett, D.A.; Diksin, M.; Chakraborty, S.; Kim, D.-H.;
et al. Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism. Cancers 2022, 14, 3873.
https://doi.org/10.3390/cancers14163873
AMA Style
Wood J, Abdelrazig S, Evseev S, Ortori C, Castellanos-Uribe M, May ST, Barrett DA, Diksin M, Chakraborty S, Kim D-H,
et al. Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism. Cancers. 2022; 14(16):3873.
https://doi.org/10.3390/cancers14163873
Chicago/Turabian Style
Wood, James, Salah Abdelrazig, Sergey Evseev, Catherine Ortori, Marcos Castellanos-Uribe, Sean T. May, David A. Barrett, Mohammed Diksin, Sajib Chakraborty, Dong-Hyun Kim,
and et al. 2022. "Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism" Cancers 14, no. 16: 3873.
https://doi.org/10.3390/cancers14163873
APA Style
Wood, J., Abdelrazig, S., Evseev, S., Ortori, C., Castellanos-Uribe, M., May, S. T., Barrett, D. A., Diksin, M., Chakraborty, S., Kim, D.-H., Grundy, R. G., & Rahman, R.
(2022). Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism. Cancers, 14(16), 3873.
https://doi.org/10.3390/cancers14163873